Japan Next Generation Cancer Diagnostics Market Size & Outlook

The next generation cancer diagnostics market in Japan is expected to reach a projected revenue of US$ 2,716.6 million by 2030. A compound annual growth rate of 12.1% is expected of Japan next generation cancer diagnostics market from 2024 to 2030.

Revenue, 2023 (US$M)
$1,222.1
Forecast, 2030 (US$M)
$2,716.6
CAGR, 2024 - 2030
12.1%
Report Coverage
Japan

Japan next generation cancer diagnostics market highlights

  • The Japan next generation cancer diagnostics market generated a revenue of USD 1,222.1 million in 2023 and is expected to reach USD 2,716.6 million by 2030.
  • The Japan market is expected to grow at a CAGR of 12.1% from 2024 to 2030.
  • In terms of segment, next generation sequencing was the largest revenue generating technology in 2023.
  • Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.


Next generation cancer diagnostics market data book summary

Market revenue in 2023USD 1,222.1 million
Market revenue in 2030USD 2,716.6 million
Growth rate12.1% (CAGR from 2023 to 2030)
Largest segmentNext generation sequencing
Fastest growing segmentNext Generation Sequencing
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNext Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays
Key market players worldwideJohnson & Johnson, Illumina Inc, Novartis AG ADR, Roche, Koninklijke Philips NV, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock


Other key industry trends

  • In terms of revenue, Japan accounted for 7.8% of the global next generation cancer diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan next generation cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,064.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Next Generation Cancer Diagnostics Market Scope

Next generation cancer diagnostics market segmentation & scope
Next Generation Sequencing
qPCR & Multiplexing
LOAC & RT-PCR
Protein Microarrays
DNA Microarrays
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
Theapeutic Monitoring
Companion Diagnostics
Prognostics
Cancer Screening
Risk Analysis

Next Generation Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website

Japan next generation cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.


Next generation sequencing was the largest segment with a revenue share of 36.92% in 2023. Horizon Databook has segmented the Japan next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.


Japanese next generation cancer diagnostics market accounted for the larger share of revenue in 2015. This large share is a resultant outcome of active expansion strategy under execution by a number of market participants to strengthen their position in Asia Pacific region of this market.

For instance, Sysmex announced in October 2014 that after their acquisition of German companies Partek and Inostics, they will establish a Japanese base in Kobe Port Island for the development of companion diagnostics. 

Furthermore, ongoing joint ventures and strategic alliances with Japanese and American companies for commercialization and development of pharmacogenomics and clinical molecular diagnostic products are also expected to fuel growth of the region.

Reasons to subscribe to Japan next generation cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan next generation cancer diagnostics market databook

  • Our clientele includes a mix of next generation cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan next generation cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Japan next generation cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan next generation cancer diagnostics market size, by technology, 2018-2030 (US$M)

Japan Next Generation Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

Japan next generation cancer diagnostics market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more